EFPIA Newsletter 18 February 2021

19 Conversations | The EFPIA podcast series     By Catherine Boudot, Director of the Trademark Department at Servier   Today we're asking Catherine Boudot, Director of the Trademark Department at Servier: "Fighting the fakes - what's industry's role?" Read more →

Blogs     18 February 2021 Pragmatic Solutions Needed for Lifecycle Management of Drug-Device Combinations (Guest Blog)... May 26, 2021 is the fast approaching date of application of the Medical Devices Regulation and with it, the requirement... Read more →         18 February 2021 What’s next in diabetes care - 100 years since the lifesaving discovery of insulin The discovery of insulin in 1921 marked the start of a medical journey that has fundamentally changed the lives of people... Read more →         18 February 2021 Ready for take-off – The launch of Europe’s Beating Cancer Plan What should we aim for by 2030? Read more →

Events     23 FEB 2021   Unlocking the Potential of Precision Medicine in Europe Virtual Event How to improve cancer care through broader access to quality biomarker testing Learn more →       24 FEB 2021   EURORDIS Black Pearl Awards Virtual Event Taking place in February to mark the occasion of Rare Disease Day, the EURORDIS Black Pearl Awards celebrate the inspirational... Learn more →

	25 FEB 2021			Blueprint for Action on Diabetes in the European Union by 2030 Virtual Event MEPs Mobilising for Diabetes Webinar Learn more →

	18 MAR 2021			Decentralised Patient-Centric Trials: From Theory to Practice Virtual / Brussels Are remote trials the future? Take a deep dive into patient-centric decentralised trial conduct and explore how these... Learn more →

News Vaccination in time of pandemic, let’s not forget the essential! Vaccines Europe, 11 February 2021 With COVID-19 pandemic, we should have learned that more than ever, all vaccines play a crucial role in public health and that, vaccines are an incredibly successful and cost-effective public health tool. Read more

What we are reading The AMR Action Fund announces its first non-industry investments 18 February 2021  (AMR action fund) Read more → EMSP Project Coordinator | Full-time position offer 18 February 2021  (European Multiple Sclerosis Platform) Read more → Pandemic showcases Belgium as Europe’s Vaccine Valley 12 February 2021  (Euractiv) Read more → Ireland is open: The biologics boom boosting the Irish economy 12 February 2021  (pharmaphorum) Read more → Pharma industry catalyst for a sustainable & resilient healthcare system in Greece 03 February 2021  (The Parliament Magazine) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe